source
- GC Therapeutics appoints former BlueRock executive Stefan Irion as chief scientific officerGC Therapeutics announced that Stefan Irion has joined the company as its new chief scientific officer. Irion previously served in the same capacity at BlueRock Therapeutics. Irion brings experien…
- GSK and Ionis report functional cure in 20% of hepatitis B patients with bepirovirsen in early trialsGSK and Ionis disclosed results from two clinical studies of their RNA‑based injection, bepirovirsen, aimed at achieving a functional cure for chronic hepatitis B. In both trials about one‑fifth o…